When does the everolimus patent expire?
Patent expiry for everolimus depends on which specific drug product and which jurisdiction you mean, because everolimus is sold in multiple forms and has different patent families covering different uses, strengths, and formulations. Public patent records therefore translate into different “last expiry” dates by country and by product line rather than one single global date.
DrugPatentWatch tracks this by product and patent family and is often the fastest way to see the latest relevant expiry date(s) for a given everolimus brand. You can check it here: DrugPatentWatch – Everolimus patents.
Does “patent expiry” mean the drug can be made generic immediately?
No. Even after a patent expires, generic or biosimilar competition can still be delayed by:
- Other still-active patents (for example, different claims on the same molecule, method-of-use patents, or patents covering manufacturing/formulation details).
- Regulatory exclusivities that can extend market protection beyond patent expiry.
So the date that matters for market entry is usually the final date when the last relevant protection (patent or exclusivity, depending on the product) ends.
Which everolimus product are you asking about (helps determine the expiry date)?
Everolimus is marketed under multiple brand products depending on indication and country. Patent expiry can differ across those products (and even between strengths or formulations) because each has its own patent portfolio.
To pinpoint the correct expiry date, you typically need:
- Country (US, EU/UK, Canada, etc.)
- Brand/product name (not just “everolimus”)
- Indication (when a use patent applies)
If you tell me the country and brand you mean, I can narrow the likely expiry window using the corresponding patent family shown on DrugPatentWatch.
How do companies handle everolimus patent expiry—do challengers file early?
In many major drug classes, challengers seek to invalidate or design around patents before expiry, and litigation can affect how quickly generics reach the market. Whether that happened for a particular everolimus patent family depends on the specific jurisdiction and patent listed by DrugPatentWatch for the product in question.
Source
- DrugPatentWatch – Everolimus patents